May 22, 2013
In a St. Joseph Healthscene report, the overall cost of drugs for type 2 diabetes almost doubled between 2001 and 2007. The new drugs pushing the rise in costs are often being used as an alternative to insulin. But a new study has found there's no evidence the new medications improve care. Experts say more studies are needed to find out out whether these new therapies are worth the extra cost.
